(Q38097532)

28 August 2017

title

Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma (English)

1 reference

28 August 2017

Krishna Pillai

1

1 reference

28 August 2017

Javed Akhter

series ordinal

2

1 reference

28 August 2017

Terence C Chua

series ordinal

3

1 reference

28 August 2017

David Lawson Morris

series ordinal

4

1 reference

28 August 2017

publication date

9 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

31

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

241-250

1 reference

Systemic enzyme therapy in oncology: effect and mode of action

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain: biochemistry, pharmacology and medical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Herbal medicines for the treatment of rhinosinusitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

COX inhibitors and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain-induced apoptosis in GI-101A breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Solution structure of bromelain inhibitor IV from pineapple stem: structural similarity with Bowman-Birk trypsin/chymotrypsin inhibitor from soybean

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Characterization of the acidic and basic limbs of a bell-shaped pH profile in the inhibitory activity of bromelain inhibitor VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Proteinase activity and stability of natural bromelain preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Isolation and characterization of two forms of an acidic bromelain stem proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Purification and characterization of multiple forms of the pineapple-stem-derived cysteine proteinases ananain and comosain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain activates murine macrophages and natural killer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Application of glycoproteomics for the discovery of biomarkers in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Structures and functions of the sugar chains of glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Perspectives on the significance of altered glycosylation of glycoproteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

A serum glycomics approach to breast cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Targeting the human MUC1 oncoprotein: a tale of two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Molecular-pathological prognostic factors of gastric cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Role of osteopontin in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Mucin dynamics in intestinal bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 cell surface mucin is a critical element of the mucosal barrier to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Downregulation of MUC1 expression and its recognition by CD8⁺ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 can interact with adenomatous polyposis coli in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The Human DF3/MUC1 carcinoma-associated antigen signals nuclear localization of the catenin p120(ctn)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Akt activation by growth factors is a multiple-step process: the role of the PH domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Induction of NF-kappaB by the Akt/PKB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC1 oncoprotein stabilizes and activates estrogen receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Mucin expression profile in pancreatic cancer and the precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain reversibly inhibits invasive properties of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Inflammation and cancer: an ancient link with novel potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Cyclooxygenases, prostanoids, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Cross-linked bromelain inhibits lipopolysaccharide-induced cytokine production involving cellular signaling suppression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Signal transduction of inflammatory cytokines and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

RAGE signaling sustains inflammation and promotes tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Genotoxicity of advanced glycation end products in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

AGE-RAGE system and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Bromelain treatment decreases neutrophil migration to sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Resistance of cancer cells to immune recognition and killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Beyond hemostasis: the role of platelets in inflammation, malignancy and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

Aspirin and NSAIDs: effects in breast and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.784777

10.3109/07357907.2013.784777

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference